electroCore, Inc.

ECOR Nasdaq SEC CIK 1560258
Follow electroCore Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $9.7M +11.5% vs same quarter last year
Net income −$1.3M +60.7% vs same quarter last year
EPS, diluted −$0.13 +67.5% vs same quarter last year
Operating cash flow −$2.8M −69.5% vs same quarter last year
Revenue by quarter
$7M
$6.7M
$7.4M
$8.7M
$9.2M
$9.6M
$9.5M
$9.7M
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income10 fiscal years
  • Revenue
  • Net income
−$75M−$50M−$25M$0$25M$50MFY17FY19FY21FY23FY25
Show the numbers
YearRevenueNet income
FY25$32M−$14M
FY24$25.2M−$11.9M
FY23$16M−$18.8M
FY22$8.6M−$22.2M
FY21$5.5M−$17.2M
FY20$3.5M−$23.5M
FY19$2.4M−$45.1M
FY18$993K−$55.8M
FY17$811.5K−$35.8M
FY16--
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−6000%−4000%−2000%0%2000%FY17FY19FY21FY23FY25
Show the numbers
YearGross marginOperating marginNet margin
FY2586.8%−41.1%−43.6%
FY2485%−48.3%−47.2%
FY2382.5%−120.2%−117.5%
FY2281.2%−266.2%−257.9%
FY2174.6%−367.7%−315.9%
FY2050.3%−707.9%−672.5%
FY1951.6%−1928.2%−1888.8%
FY1841.7%−5494.1%−5621.7%
FY1736.1%−3160.3%−4410.9%
FY16---
Free cash flowOperating cash flow minus capital expenditure
−$60M−$40M−$20M$0FY17FY19FY21FY23FY25
Show the numbers
YearFree cash flow
FY25−$8.3M
FY24-
FY23−$14.9M
FY22-
FY21-
FY20-
FY19−$45.1M
FY18−$47.4M
FY17−$25.5M
FY16-
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • electroCore
  • Healthcare median
−6000%−4000%−2000%0%FY17FY19FY21FY23FY25
Show the numbers
YearelectroCoreHealthcare median
FY25−43.6%−30.8%
FY24−47.2%−47%
FY23−117.5%−58%
FY22−257.9%−80.4%
FY21−315.9%−71.9%
FY20−672.5%−62.2%
FY19−1888.8%−46.3%
FY18−5621.7%−49.6%
FY17−4410.9%−45.9%
FY16-−36%